R&D

Overview

Ulcerative Colitis Drug AGM-260
AGM-260, a orphan G protein coupled receptor (oGPCR) agonist improved the treatment with Colitis models.
  • AGM-260 inhibited inflammatory effects in colon cell lines.

  • The administration of AGM-260 had therapeutic effects in Ulcerative colitis mouse models.